Shailaja Jadhav | Pharmaceutics | Women Researcher Award

Posted on by ScienceFather

Mrs. Shailaja Jadhav | Pharmaceutics | Women Researcher Award

Assistant Professor at Gourishankar Institute of Pharmaceutical Education and Research Limb, Satara, India.

Mrs. Shailaja Vishal Jadhav is a dedicated researcher and academic in the field of pharmaceutical sciences, with a focus on advanced drug delivery systems and nanotechnology. Currently pursuing her Ph.D., she has demonstrated a strong commitment to research and education, holding an assistant professor position and contributing to her field through publications and presentations. Her work is recognized nationally, and she continues to push the boundaries of pharmaceutical research with her innovative approaches.

Profile:

Education

Mrs. Jadhav holds a Bachelor’s degree in Pharmacy (B. Pharm) and a Master’s degree in Pharmacy (M. Pharm) from Shivaji University, Kolhapur. She is currently pursuing her Ph.D. at the Government College of Pharmacy, Karad, under Shivaji University, where she has submitted her final thesis, awaiting her viva examination. Her solid academic foundation is reflected in her consistent academic performance, with notable scores during her undergraduate and postgraduate studies.

 

Professional Experiences 

Mrs. Jadhav brings a wealth of both academic and industrial experience to her career. She has accumulated over eight years of teaching experience, including five years as an Assistant Professor at the Gourishankar Institute of Pharmaceutical Education and Research in Satara. Additionally, she has undergone industrial training at Meditab Specialities Pvt. Ltd., where she gained practical exposure to pharmaceutical processes. This combination of academic instruction and hands-on experience in the industry has enriched her practical and theoretical knowledge in pharmaceutical sciences.

Research Interests

Mrs. Shailaja Vishal Jadhav’s research interests are primarily focused on Novel Drug Delivery Systems (NDDS), formulation and development, and nanotechnology. She is passionate about exploring innovative approaches to improve the efficacy and safety of drug delivery. Her Ph.D. research revolves around the extraction and quantification of bioactive compounds, specifically focusing on Supercritical CO2 Extraction and the pharmacological screening of Steroidal Saponins from natural sources. Additionally, her interest in nanotechnology aims at developing nanoscale drug delivery methods that can enhance targeted therapies and minimize side effects, making her work highly relevant in the fields of pharmaceutical and biomedical sciences.

 

Research skills 

Her research expertise lies in Novel Drug Delivery Systems (NDDS), formulation and development, and nanotechnology. She is proficient in using sophisticated laboratory instruments such as HPLC, UV/Visible spectrophotometer, and particle size analyzers, which are critical for her research. Her Ph.D. research focuses on supercritical CO2 extraction and steroidal saponins, reflecting her skills in both cutting-edge extraction techniques and pharmacological screening. Her ability to combine advanced scientific methods with real-world applications makes her a strong asset to the research community.

 

Award And Recoginition 

Mrs. Jadhav has received multiple awards and recognitions throughout her academic journey. Most notably, she was awarded the prestigious Chhatrapati Shahu Maharaj National Research Fellowship (CSMNRF-2020) by the Government of Maharashtra for her Ph.D. research. She secured the 3rd rank in the Shivaji University Ph.D. Entrance Examination and achieved 2nd place in an international symposium poster presentation. Her research work has also been published in a high-impact journal, underscoring the quality and significance of her contributions to pharmaceutical science.

 

Conclusion

Mrs. Shailaja Vishal Jadhav’s academic qualifications, research achievements, and diverse professional experience make her a strong candidate for the Research for Women Researcher Award. Her current Ph.D. pursuit, national fellowship, and publication record demonstrate her potential for significant contributions to her field. Finalizing her Ph.D. and expanding her research outputs could further elevate her candidacy.

 

Publication Top Notes
  • Title: Natural Polymer-Based Formulation and Characterization of Matrix-Controlled Release Tablet of Losartan Potassium Employing Sintering Technique
    Authors: Dr. A. S. Kulkarni, S. V. Jadhav*, Dr. N. H. Aloorkar
    Year: 2019
    Citation: European Journal of Biomedical and Pharmaceutical Sciences, Volume 6, Issue 10, 312-322
    📅💊🌿
  • Title: Phytoconstituents Based Nanomedicines for the Management of Diabetes: A Review
    Authors: Shailaja Jadhav*, Dr. Adhikarao Yadav
    Year: 2023
    Citation: Pharmaceutical Nanotechnology, Bentham Science Publisher, Volume 11, Issue 3, 217-237. DOI: 10.2174/2211738511666230118095936
    🌱🧪🔬
  • Title: Supercritical CO2 Extraction, Quantification, and Pharmacological Screening of Steroidal Saponins from Fruits of Momordica Charantia L
    Authors: Shailaja Jadhav*, Adhikrao Yadav
    Year: 2023
    Citation: International Journal of Pharmaceutical Quality Assurance, Volume 14, Issue 3, July-September, 563-572
    🍈💧⚗️
  • Title: Molecular Docking Studies of Antidiabetic Biomolecule Charantin Isolated from Fruits of Momordica Charantia L
    Authors: Shailaja Jadhav*, Adhikrao Yadav
    Year: 2024
    Citation: Advances in Bioresearch, Volume 15, Issue 2, March 2024, 182-189. DOI: 10.15515/abr.0976-4585.15.2.182189
    🧬🔍🧫
  • Title: Enhanced Antidiabetic Performance Through Optimized Charantin-Loaded Nanostructured Lipid Carriers: Formulation and In Vivo Studies in Diabetic Mice
    Authors: Shailaja Jadhav*, Dr. Adhikarao Yadav, Sameer Nadaf
    Year: 2024
    Citation: Journal of Drug Delivery Science and Technology. DOI: 10.1016/j.jddst.2024.106208
    🧑‍🔬🐭💉

Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award

Posted on by ScienceFather

Dr. Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award

Associate Professor at Quaid-i-Azam University, Pakistan

Dr. Kifayat Ullah Shah is an accomplished academic and researcher in the field of pharmaceutical sciences, currently serving as an Associate Professor at Quaid-e-Azam University in Islamabad since September 2014. He previously held positions as an Assistant Professor at Hamdard University and a Teaching Assistant at Gomal University. Dr. Shah earned his Ph.D. in Pharmaceutics from Gomal University, where he also completed his Bachelor of Pharmacy. His research interests include the formulation and development of pharmaceuticals, controlled drug delivery, and nanotechnology applications in drug delivery. He has authored several publications with significant impact, reflecting his contributions to the field, and has supervised over 35 MPhil and five PhD students. Dr. Shah has received grants for various research projects, showcasing his commitment to advancing pharmaceutical sciences. Additionally, he is actively involved in academic administration and quality assurance within higher education.

Profile

Education

Dr. Kifayat Ullah Shah holds an impressive educational background in pharmaceutical sciences. He earned his Doctor of Philosophy (Ph.D.) in Pharmaceutics from Gomal University, Dera Ismāīl Khān, Khyber Pakhtunkhwa, Pakistan, between 2008 and 2014. Prior to that, he obtained a Bachelor of Pharmacy (B.Pharmacy) degree from the same institution, Gomal University, from 2002 to 2006. His early education includes a Pre-Medical F.Sc. from Govt. P.G. College Bannu in 2000-2001 and Matriculation in Science from Govt. High School-02 Bannu in 1998-1999. This strong academic foundation has equipped Dr. Shah with the knowledge and skills necessary to excel in both research and teaching within the field of pharmaceutical sciences.

Professional Experience

Dr. Kifayat Ullah Shah has extensive professional experience in academia and the pharmaceutical industry. He has served as an Associate Professor at Quaid-e-Azam University, Islamabad, since September 2014, where he has contributed to teaching and research in pharmaceutical sciences. Prior to this role, Dr. Shah was an Assistant Professor at Hamdard University from January to August 2014 and worked as a Teaching Assistant at Gomal University for a brief period in late 2011. His early career included experience as a Production Pharmacist at Glitz Pharmaceuticals in Islamabad, where he gained practical insights into pharmaceutical production and formulation. Dr. Shah’s diverse professional background, coupled with his research focus on drug delivery systems and nanotechnology, has positioned him as a prominent figure in his field.

Research Interest

Dr. Kifayat Ullah Shah’s research interests are centered around the formulation and development of pharmaceutical products, with a particular focus on controlled drug delivery systems. His expertise encompasses a variety of advanced techniques, including microencapsulation, nanotechnology, and thermal analysis, which he applies to improve the efficacy and safety of drug formulations. Dr. Shah has conducted significant research on targeted drug delivery mechanisms, exploring innovative methods to enhance therapeutic outcomes for various medical conditions. His work also includes the design, preparation, and evaluation of controlled release polymeric formulations, aiming to investigate drug release patterns and mechanisms. Through his research, Dr. Shah seeks to contribute to the advancement of pharmaceutical sciences and improve patient care through effective drug delivery systems.

Research Skills

Dr. Kifayat Ullah Shah possesses a robust skill set in pharmaceutical research, particularly in the formulation and development of drug delivery systems. His expertise includes advanced techniques such as microencapsulation, controlled drug delivery, and targeted drug delivery, which are essential for optimizing the therapeutic effects of pharmaceuticals. Dr. Shah is proficient in utilizing various analytical instruments, including UV/Visible spectrophotometry, differential scanning calorimetry (DSC), and thermal analysis, to evaluate and characterize pharmaceutical formulations. His research skills also extend to pre-formulation studies and the application of nanotechnology in drug delivery, enabling him to design innovative solutions for complex pharmaceutical challenges. Through his comprehensive knowledge and practical experience, Dr. Shah effectively contributes to the advancement of pharmaceutical sciences and the development of new therapeutic strategies.

Award and Recognition

Dr. Kifayat Ullah Shah has garnered several awards and recognitions throughout his career, highlighting his significant contributions to the field of pharmaceutics. He successfully obtained funding for key research projects, including a grant of 0.5 million PKR from the Higher Education Commission (HEC) of Pakistan for the fabrication, characterization, and in vitro evaluation of finasteride nanoparticles. Additionally, he received a substantial grant of 4.5 million PKR for his project on silica-based nanoparticles as hemostatic agents for controlling internal bleeding. Dr. Shah has also been recognized for his academic excellence, having supervised over 35 MPhil and five PhD students, and for his impactful research publications, which have contributed to advancements in drug delivery systems. His work has earned him respect and acknowledgment in the academic and research communities, reflecting his dedication to enhancing pharmaceutical sciences and improving patient care.

Conclusion

Dr. Kifayat Ullah Shah’s impressive academic credentials, extensive research experience, impactful publications, successful funding acquisitions, and contributions to education and administrative services strongly position him as a deserving candidate for the Research for Best Researcher Award. His ongoing commitment to advancing pharmaceutical sciences through research and mentorship further strengthens his suitability for this recognition.

Publication Top Notes

  • “Non-pharmacological management of hypertension: in the light of current research”
    • Journal: Irish Journal of Medical Science (1971-)
    • Cited by: 180
    • Year: 2019
    • Volume: 188
    • Pages: 437-452
  • “From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)”
    • Journal: Expert Opinion on Drug Delivery
    • Cited by: 148
    • Year: 2017
    • Volume: 14, Issue 11
    • Pages: 1325-1340
  • “Proniosomes derived niosomes: recent advancements in drug delivery and targeting”
    • Journal: Drug Delivery
    • Cited by: 121
    • Year: 2017
    • Volume: 24, Issue 2
    • Pages: 56-69
  • “A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers”
    • Journal: Carbohydrate Polymers
    • Cited by: 106
    • Year: 2020
    • Volume: 250
    • Pages: 116800
  • “Elemental analysis of some medicinal plants used in traditional medicine by atomic absorption spectrophotometer (AAS)”
    • Journal: Journal of Medicinal Plants Research
    • Cited by: 93
    • Year: 2010
    • Volume: 4, Issue 19
    • Pages: 1987-1990
  • “Polymeric nanogels as versatile nanoplatforms for biomedical applications”
    • Journal: Journal of Nanomaterials
    • Cited by: 81
    • Year: 2019
    • Volume: 2019, Issue 1
    • Pages: 1526186
  • “Hemostatic strategies for uncontrolled bleeding: A comprehensive update”
    • Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials
    • Cited by: 73
    • Year: 2021
    • Volume: 109
  • “Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product”
    • Journal: Journal of Drug Delivery Science and Technology
    • Cited by: 72
    • Year: 2019
    • Volume: 51
    • Pages: 583-590
  • “Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis”
    • Journal: International Journal of Clinical Pharmacy
    • Cited by: 56
    • Year: 2021
    • Volume: 43
    • Pages: 486-501
  • “Co-delivery strategies to overcome multidrug resistance in ovarian cancer”
    • Journal: International Journal of Pharmaceutics
    • Cited by: 47
    • Year: 2017
    • Volume: 533, Issue 1
    • Pages: 111-124
  • “Regulating drug release behavior and kinetics from matrix tablets based on fine particle‐sized ethyl cellulose ether derivatives: An in vitro and in vivo evaluation”
    • Journal: The Scientific World Journal
    • Cited by: 46
    • Year: 2012
    • Volume: 2012, Issue 1
    • Pages: 842348